Related Experiment Video

Updated: May 24, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

[Monitoring of vancomycin in pediatrics]

A Delicourt1, K Touzin, A Lavoie

  • 1Département de pharmacie, CHU Sainte-Justine, 3175 Côte-Ste-Catherine, Montréal, Québec, Canada.

Medecine Et Maladies Infectieuses
|March 20, 2012
PubMed

Insights

Current pediatric vancomycin dosing practices often fail to achieve target serum concentrations. A review of 30 patients found only 60% reached therapeutic trough levels by day five, suggesting a need for revised monitoring protocols.

Area of Science:

  • Pharmacology
  • Pediatric Medicine
  • Clinical Pharmacy

Context:

  • Vancomycin is a critical antibiotic for treating serious Gram-positive infections in children.
  • Optimizing vancomycin therapy requires achieving specific serum concentrations to maximize efficacy and minimize toxicity.
  • Current pediatric vancomycin prescription and monitoring practices are under review for effectiveness.

Purpose:

  • To evaluate the efficacy of current local pediatric practices in achieving therapeutic vancomycin serum concentrations.
  • To assess vancomycin trough and peak levels in pediatric patients receiving the antibiotic for at least five days.

Summary:

  • A retrospective study analyzed 30 pediatric patients treated with vancomycin at Sainte-Justine university hospital center.
  • Results indicated that only 60% of patients achieved target trough levels (5-10 mg/L) and 33% achieved target peak levels (20-40 mg/L) by day five.
  • The findings suggest current practices are insufficient for consistently reaching therapeutic vancomycin concentrations.

Impact:

  • The study highlights a significant gap between prescribed vancomycin dosing strategies and desired therapeutic outcomes in pediatric patients.
  • Recommendations include reconsidering the target range for vancomycin trough levels to improve treatment efficacy.
  • This research can inform the development of more effective vancomycin therapeutic drug monitoring guidelines in pediatric care.
Abstract

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...